We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Arcosa
ACA
$7.11B
| $10.6M | ﹤0.01% |
185,119
+11,297
| +6% | +$626K |
|
1427
Simpson Manufacturing
SSD
$8.16B
| $10.6M | ﹤0.01% |
134,779
-6,016
| -4% | -$582K |
|
1428
Payoneer
PAYO
$2.41B
| $10.5M | ﹤0.01% |
1,733,689
+1,099,553
| +173% | +$6.39M |
|
1429
WSFS Financial
WSFS
$4.15B
| $10.5M | ﹤0.01% |
225,668
-189,323
| -46% | -$8.85M |
|
1430
Guidewire Software
GWRE
$14.2B
| $10.5M | ﹤0.01% |
170,184
-3,288
| -2% | -$238K |
|
1431
Enova International
ENVA
$6.29B
| $10.4M | ﹤0.01% |
356,966
-2,015
| -0.6% | -$67.6K |
|
1432
Procept Biorobotics
PRCT
$1.17B
| $10.4M | ﹤0.01% |
250,912
+75,521
| +43% | +$3.01M |
|
|
ZUO
1433
DELISTED
Zuora, Inc.
ZUO
| $10.3M | ﹤0.01% |
1,402,009
+14,266
| +1% | +$123K |
|
1434
BWX Technologies
BWXT
$15.6B
| $10.3M | ﹤0.01% |
205,224
-9,788
| -5% | -$528K |
|
1435
Titan Machinery
TITN
$445M
| $10.3M | ﹤0.01% |
365,461
+12,987
| +4% | +$368K |
|
1436
Seagate
STX
$184B
| $10.3M | ﹤0.01% |
193,957
+53,280
| +38% | +$3.85M |
|
1437
Teladoc Health
TDOC
$1.3B
| $10.3M | ﹤0.01% |
405,553
-22,942
| -5% | -$805K |
|
1438
Watts Water Technologies
WTS
$13.1B
| $10.3M | ﹤0.01% |
81,709
-1,298
| -2% | -$176K |
|
1439
QuidelOrtho
QDEL
$838M
| $10.3M | ﹤0.01% |
143,556
-209,326
| -59% | -$18.7M |
|
1440
Neogen
NEOG
$2.5B
| $10.3M | ﹤0.01% |
734,232
-628
| -0.1% | -$12.6K |
|
|
VERV
1441
DELISTED
Verve Therapeutics
VERV
| $10.3M | ﹤0.01% |
298,384
+148,964
| +100% | +$4.75M |
|
1442
Gray Television
GTN
$552M
| $10.2M | ﹤0.01% |
715,113
+53,169
| +8% | +$975K |
|
1443
Integra LifeSciences
IART
$1.34B
| $10.2M | ﹤0.01% |
240,723
+5,584
| +2% | +$286K |
|
1444
Natera
NTRA
$46.4B
| $10.2M | ﹤0.01% |
232,576
-1,578
| -0.7% | -$75.1K |
|
1445
Kulicke & Soffa
KLIC
$4.78B
| $10.2M | ﹤0.01% |
264,431
-13,418
| -5% | -$594K |
|
1446
OSI Systems
OSIS
$3.89B
| $10.2M | ﹤0.01% |
141,382
-32,976
| -19% | -$2.89M |
|
1447
Arcutis Biotherapeutics
ARQT
$3.18B
| $10.2M | ﹤0.01% |
532,875
+171,732
| +48% | +$3.89M |
|
1448
American States Water
AWR
$3.46B
| $10.2M | ﹤0.01% |
130,432
+8,995
| +7% | +$764K |
|
1449
LCI Industries
LCII
$2.65B
| $10.1M | ﹤0.01% |
99,620
-726
| -0.7% | -$88.3K |
|
1450
International Money Express
IMXI
$367M
| $10.1M | ﹤0.01% |
443,199
+208,133
| +89% | +$4.89M |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.